Literature DB >> 3326547

Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine.

H Remmer1.   

Abstract

The difficulties in defining the exposure of a passive smoker might explain the controversial results regarding an association between passive smoking on one hand and lung cancer, tumors of all sites and ischemic heart diseases on the other. The plausibility of these epidemiological observations will be discussed in the light of analytical, toxicological, biochemical and oncological data. The minute amounts of nicotine and particulate matter, even the much higher concentrations of volatile substances, such as nitrosamines, NOx, acroleine and formaldehyde, present in diluted sidestream compared to mainstream smoke and breathed by involuntarily smoking people, cannot explain their relatively high cancer risk. It is plausible if one considers the high capacity of cigarette smoke to induce drug metabolizing enzymes. Diluted sidestream smoke, however, lacks compounds which induce several iso-enzymes of cyt. P-450 monooxygenase in the tissues. The best evidence is the up to 100-fold increase in placental enzymes if pregnant women smoke, whereas passively inhaled tobacco smoke is ineffective as inducer. The small amounts of paternal smoke inhaled by pregnant women, containing teratogenic and carcinogenic compounds, which are supposedly not detoxified in the placenta, seem to explain the higher risk for malformations of the fetus and the same or even increased risk for perinatal mortality, compared with the outcome of pregnancy if the mother smoked. The induction of placental enzymes very probably protects the fetus against the much higher amounts of toxic agents inhaled by the smoking mother. The increased activity of placental enzymes seems to be a model for the probably greater capacity of certain cyt. P-450 iso-enzymes in the lung and other tissues to convert carcinogens to inactive metabolites when the individual smokes actively. It is well known that concomitant administration of carcinogens with inducing agents inhibits tumor growth in animals because of a shift in the metabolism which favours the formation of ineffective substances. The negligible amounts of nicotine and CO in passively inhaled tobacco smoke cannot be responsible for the surprisingly high risk for ischemic heart diseases of passive smokers. A plausible explanation is offered by experiments with doves and chicken, which develop atherosclerotic lesions due to the action of carcinogens which are metabolized by certain inducible cyt. P-450 iso-enzymes in the aortic wall. Much circumstantial evidence will be presented, indicating that PAHs, contrary to the propagated opinion, play a minor role for the initiation of cancer in active smokers.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3326547     DOI: 10.1007/bf00661366

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  152 in total

1.  The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene.

Authors:  A H CONNEY; E C MILLER; J A MILLER
Journal:  Cancer Res       Date:  1956-06       Impact factor: 12.701

2.  Human placental hydroxylation of 3,4-benzpyrene during early gestation and at term.

Authors:  M R Juchau
Journal:  Toxicol Appl Pharmacol       Date:  1971-03       Impact factor: 4.219

3.  Phenobarbital-mediated increase in ring- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide, and decrease in amounts bound to liver deoxyribonucleic acid.

Authors:  T Matsushima; P H Grantham; E K Weisburger; J H Weisburger
Journal:  Biochem Pharmacol       Date:  1972-08-01       Impact factor: 5.858

4.  Pulmonary changes in 7,000 mice following prolonged exposure to ambient and filtered Los Angeles air.

Authors:  M B Gardner; C G Loosli; B Hanes; W Blackmore; D Teebken
Journal:  Arch Environ Health       Date:  1970-03

5.  Passive smoking and lung cancer.

Authors:  P Correa; L W Pickle; E Fontham; Y Lin; W Haenszel
Journal:  Lancet       Date:  1983-09-10       Impact factor: 79.321

6.  Cancer, passive smoking and nonemployed and employed wives.

Authors:  G H Miller
Journal:  West J Med       Date:  1984-04

7.  Measuring passive smoking: methods, problems, and perspectives.

Authors:  L C Johnson; H W Letzel
Journal:  Prev Med       Date:  1984-11       Impact factor: 4.018

Review 8.  Update on the role of cigarette smoking in coronary artery disease.

Authors:  W B Kannel
Journal:  Am Heart J       Date:  1981-03       Impact factor: 4.749

9.  Organ specificity of induction of activating and inactivating enzymes by cigarette smoke and cigarette smoke condensate.

Authors:  J E Gielen; F Goujon; J Sele; J Van Canfort
Journal:  Arch Toxicol Suppl       Date:  1979

10.  Potent induction of human placental mono-oxygenase activity by previous dietary exposure to polychlorinated biphenyls and their thermal degradation products.

Authors:  T K Wong; R B Everson; S T Hsu
Journal:  Lancet       Date:  1985-03-30       Impact factor: 79.321

View more
  8 in total

1.  Elevated blood levels of carcinogens in passive smokers.

Authors:  M Maclure; R B Katz; M S Bryant; P L Skipper; S R Tannenbaum
Journal:  Am J Public Health       Date:  1989-10       Impact factor: 9.308

2.  Elimination of cotinine from body fluids: disposition in smokers and nonsmokers.

Authors:  N J Haley; D W Sepkovic; D Hoffmann
Journal:  Am J Public Health       Date:  1989-08       Impact factor: 9.308

Review 3.  Importance of exposure to gaseous and particulate phase components of tobacco smoke in active and passive smokers.

Authors:  G Scherer; C Conze; L von Meyerinck; M Sorsa; F Adlkofer
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

4.  Uptake of tobacco smoke constituents on exposure to environmental tobacco smoke (ETS).

Authors:  G Scherer; C Conze; A R Tricker; F Adlkofer
Journal:  Clin Investig       Date:  1992 Mar-Apr

5.  Hydroxyethylvaline adduct formation in haemoglobin as a biological monitor of cigarette smoke intake.

Authors:  E Bailey; A G Brooks; C T Dollery; P B Farmer; B J Passingham; M A Sleightholm; D W Yates
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

6.  Exposure to environmental tobacco smoke among South Korean adults: a cross-sectional study of the 2005 Korea National Health and Nutrition Examination Survey.

Authors:  Bo-Eun Lee; Eun-Hee Ha
Journal:  Environ Health       Date:  2011-04-03       Impact factor: 5.984

7.  Lung cancer and passive smoking.

Authors:  P Lee
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

8.  Highlight report: Validation of prognostic genes in lung cancer.

Authors:  Rosemarie Marchan
Journal:  EXCLI J       Date:  2014-05-06       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.